• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    7/20/23 1:26:43 PM ET
    $ABVC
    $ALPS
    $AWH
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $ABVC alert in real time by email

    Gainers

    • PainReform Ltd. (NASDAQ:PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 22.8% to $0.1255 after the FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test.
    • SigmaTron International, Inc. (NASDAQ:SGMA) shares climbed 25.3% to $4.4861 after the company reported results for the fourth quarter.
    • Pasithea Therapeutics Corp. (NASDAQ:KTTA) gained 21% to $0.5790 after the company rejected an unsolicited, non-binding acquisition proposal from Lucy Scientific Discovery. The company also authorized the repurchase of up to 5.7 million shares at $0.70/share.
    • Kuke Music Holding Limited (NYSE:KUKE) climbed 16.5% to $0.55.
    • Dynatronics Corporation (NASDAQ:DYNT) climbed 15% to $0.8998.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares gained 14.4% to $0.5434 after gaining around 14% on Wednesday.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) rose 14.4% to $2.61 after the company announced a strategic relationship with British Telecom to deliver an AI-powered innovative Smart Port solution.
    • Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) gained 12.3% to $22.59.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) rose 11.6% to $3.54.
    • Catalyst Biosciences, Inc. (NASDAQ:CBIO) gained 11.2% to $0.4099.
    • Heritage-Crystal Clean, Inc (NASDAQ:HCCI) climbed 9.6% to $45.96 after the company announced it will be acquired by J.F. Lehman & Company for $1.2 billion.
    • Zions Bancorporation, National Association (NASDAQ:ZION) rose 9.4% to $37.72 after the company reported second-quarter earnings results.
    • Select Medical Holdings Corporation (NYSE:SEM) gained 9.1% to $32.87.
    • Nanobiotix S.A. (NASDAQ:NBTX) shares climbed 8.4% to $7.77 as the company said first patient was injected in new Phase 1/2 study evaluating radiotherapy-activated NBTXR3 plus anti-PD-1 for patients with advanced cancers.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 8% to $0.50.

    Losers

    • Vir Biotechnology, Inc. (NASDAQ:VIR) shares fell 43.4% to $13.04 after the company's Phase 2 PENINSULA trial of VIR-2482 for the prevention of symptomatic influenza A illness did not meet primary or secondary efficacy endpoints.
    • Netcapital Inc. (NASDAQ:NCPL) fell 40.2% to $0.70 after the company announced pricing of a public offering.
    • Aspira Women's Health Inc. (NASDAQ:AWH) fell 30.6% to $2.76 after the company announced a registered direct offering of around 1.7 million shares at $2.75 per share and $3.98 per share for directors & officers, for gross proceeds of approximately $4.7 million.
    • DURECT Corporation (NASDAQ:DRRX) dipped 29.9% to $3.45 after the company announced a $15 million registered direct offering priced at-the-market under Nasdaq rules.
    • Cosmos Health Inc. (NASDAQ:COSM) declined 22.5% to $1.9199 after the company priced $5.25 million registered direct offering and concurrent private placement at combined price of $2.48.
    • NVE Corporation (NASDAQ:NVEC) shares tumbled 17% to $80.18 following first-quarter results.
    • Alpine Summit Energy Partners, Inc. (NASDAQ:ALPS) fell 16.8% to $0.1483 after declining around 8% on Wednesday. The company recently filed for voluntary chapter 11 relief in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division.
    • JX Luxventure Limited (NASDAQ:JXJT) shares fell 16.6% to $2.16. JX Luxventure shares gained 11% on Wednesday after the company reported a new artificial intelligence initiative.
    • Discover Financial Services (NYSE:DFS) fell 14.7% to $104.00 after the company reported downbeat quarterly earnings and announced a share buyback pause.
    • Richardson Electronics, Ltd. (NASDAQ:RELL) fell 13.3% to $13.49 after the company reported worse-than-expected fourth-quarter earnings results.
    • Mallinckrodt plc (NYSE:MNK) declined 12.5% to $0.5950.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares tumbled 12.4% to $2.8893.
    • Vroom, Inc. (NASDAQ:VRM) fell 11.4% to $2.3650.
    • Infosys Limited (NYSE:INFY) shares declined 9.4% to $16.05 after the company reported worse-than-expected quarterly earnings results.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) declined 8.8% to $2.3150. Ginkgo Bioworks was granted a four-year contract by the Defense Advanced Research Projects Agency (DARPA) worth up to $18 million.
    • Quantum-Si incorporated (NASDAQ:QSI) fell 8.7% to $3.24.
    • Netflix, Inc. (NASDAQ:NFLX) fell 8.4% to $437.57. Netflix reported upbeat earnings for the second quarter, while sales missed expectations.
    • Mobileye Global Inc. (NASDAQ:MBLY) tumbled 8.2% to $39.93.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) fell 7.9% to $0.3869.
    • Columbia Banking System, Inc. (NASDAQ:COLB) declined 7.7% to $21.73 after the company reported worse-than-expected second-quarter EPS results.
    • ManpowerGroup Inc. (NYSE:MAN) fell 7.5% to $82.18 following weak quarterly earnings.
    • SL Green Realty Corp. (NYSE:SLG) shares fell 7% to $33.45 after the company reported lower-than-expected Q2 sales results.
    • Genuine Parts Company (NYSE:GPC) declined 6.5% to $157.16 following second-quarter results.
    • Tesla, Inc. (NASDAQ:TSLA) fell 6.4% to $272.65. Tesla reported better-than-expected earnings and sales results for its second quarter, but said operating margin narrowed to 9.6% from 14.6% in the year-ago period.
    • Carvana Co. (NYSE:CVNA) dipped 6.2% to $52.33. RBC Capital downgraded Carvana from Sector Perform to Underperform and raised the price target from $9 to $30.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) declined 5.8% to $285.79. Supermicro announced preliminary financial results for the fourth quarter.
    • Crown Castle Inc. (NYSE:CCI) shares fell 5.8% to $106.88 after the company reported second-quarter results and issued weak FY23 earnings outlook.

     

    Now Read This: Check Out 3 High-Yielding Dividend Stocks In Tech And Telecom Sector From Wall Street's Most Accurate Analysts

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ALPS
    $AWH
    $CBIO

    CompanyDatePrice TargetRatingAnalyst
    Zions Bancorporation N.A.
    $ZION
    3/12/2026Neutral
    Brean Capital
    Netflix Inc.
    $NFLX
    3/9/2026$105.00Equal Weight
    Wells Fargo
    Zions Bancorporation N.A.
    $ZION
    3/9/2026$65.00Neutral → Outperform
    Robert W. Baird
    Crown Castle Inc.
    $CCI
    3/5/2026$102.00Outperform
    Bernstein
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Select Medical Holdings Corporation
    $SEM
    3/3/2026$16.50Outperform → Sector Perform
    RBC Capital Mkts
    Netflix Inc.
    $NFLX
    3/2/2026$115.00Equal Weight
    Barclays
    Netflix Inc.
    $NFLX
    3/2/2026$120.00Overweight
    Analyst
    More analyst ratings

    $ABVC
    $ALPS
    $AWH
    $CBIO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XDEMVY issued to TARSUS PHARMACEUTICALS, INC.

    Submission status for TARSUS PHARMACEUTICALS, INC.'s drug XDEMVY (ORIG-1) with active ingredient LOTILANER has changed to 'Approval' on 07/24/2023. Application Category: NDA, Application Number: 217603, Application Classification: Type 1 - New Molecular Entity

    7/25/23 4:35:13 PM ET
    $TARS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for issued to TARSUS PHARMACEUTICALS, INC.

    Submission status for TARSUS PHARMACEUTICALS, INC.'s drug (ORIG-1) with active ingredient has changed to 'Approval' on 07/24/2023. Application Category: NDA, Application Number: 217603, Application Classification: Type 1 - New Molecular Entity

    7/25/23 4:35:13 PM ET
    $TARS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for issued to TARSUS PHARMACEUTICALS, INC

    Submission status for TARSUS PHARMACEUTICALS, INC's drug (SUPPL-1) with active ingredient has changed to 'Approval' on 07/24/2023. Application Category: NDA, Application Number: 217603, Application Classification: Type 1 - New Molecular Entity

    7/25/23 4:29:16 PM ET
    $TARS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SL Green Announces the Sale of 7 Dey Street

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it has entered into a contract to sell the residential and retail components of 7 Dey Street for total consideration of $222.6 million to GO Residential (TSX:GO). SL Green will retain ownership of the 26,000 square foot office component of the property. The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions. "This transaction continues the execution of a deliberate strategy to illuminate the value of selected assets and unlock embedded value," said Harrison Sitomer, President and Chief Investment Offic

    3/16/26 6:19:33 PM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    Supermicro Launches Seven AI Data Platform Solutions with NVIDIA and Leading Ecosystem Partners to Accelerate Enterprise AI Innovation

    Supermicro's advanced GPU and storage architectures form the backbone of seven next-generation AI Data Platform solutions.Built with industry leaders including Cloudian, DDN, Everpure (formerly Pure Storage), IBM, Nutanix, VAST Data, and WEKA to deliver fully integrated, enterprise-ready AI infrastructure.Purpose-built AI Data Platforms unlock the full value of enterprise data — accelerating insight, automation, and intelligent transformation at scale.SAN JOSE, Calif., March 16, 2026 /PRNewswire/ -- Supermicro, Inc. (NASDAQ:SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced seven fully integrated AI Data Platform solutions designed to accelerate enterpri

    3/16/26 4:35:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Supermicro Reveals DCBBS® with New NVIDIA Vera Rubin NVL72, HGX Rubin NVL8, and Vera CPU Systems, Designed to Accelerate Customer Time-to-Market

    Supermicro's NVIDIA Vera Rubin NVL72 and HGX Rubin NVL8 systems are built on the DCBBS liquid-cooling stack, targeting up to 10x throughput per watt and one-tenth the token cost, compared to NVIDIA Blackwell solutions.Supermicro's 2U HGX Rubin NVL8 system is the most flexible platform supporting NVIDIA Vera and next-generation x86 CPUs, scaling to 72 Rubin GPUs per rack, as well as a DCBBS Liquid-to-Air (L2A) Sidecar CDU option for data centers without liquid-cooling.Supermicro's new NVIDIA Vera CPU systems include a 2U server supporting up to 6 RTX PRO 4500 Blackwell Server Edition GPUs and a new AI storage system for context memory extension integrated with NVIDIA BlueField-4 DPU.SAN JOSE,

    3/16/26 4:35:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Platt Ira J. transferred by will 850 shares), transferred by will 425 shares) and exercised 10,000 shares at a strike of $15.00, increasing direct ownership by 38% to 36,105 units (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    3/16/26 5:00:27 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Chief Financial Officer Keyes Jeffry R. was granted 652,803 shares, increasing direct ownership by 56% to 1,816,000 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/16/26 4:19:21 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Product Officer Vieceli John S. was granted 391,681 shares, increasing direct ownership by 49% to 1,192,654 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/16/26 4:14:14 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $ABVC
    $ALPS
    $AWH
    $CBIO
    SEC Filings

    View All

    SEC Form 144 filed by Gorilla Technology Group Inc.

    144 - Gorilla Technology Group Inc. (0001903145) (Subject)

    3/16/26 12:23:44 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by 60 Degrees Pharmaceuticals Inc.

    424B5 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer)

    3/13/26 5:17:36 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    60 Degrees Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer)

    3/13/26 5:15:16 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dowdy Paula bought $104,450 worth of shares (109,890 units at $0.95), increasing direct ownership by 69% to 269,107 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:13 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Director Kummeth Charles R. bought $459,800 worth of shares (500,000 units at $0.92), increasing direct ownership by 141% to 855,000 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:59 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chairman & CEO Simmons Harris H bought $265,635 worth of shares (4,500 units at $59.03), increasing direct ownership by 0.34% to 1,317,493 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/25/26 4:33:19 PM ET
    $ZION
    Major Banks
    Finance

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Brean Capital resumed coverage on Zions Bancorp

    Brean Capital resumed coverage of Zions Bancorp with a rating of Neutral

    3/12/26 3:51:49 PM ET
    $ZION
    Major Banks
    Finance

    Wells Fargo resumed coverage on Netflix with a new price target

    Wells Fargo resumed coverage of Netflix with a rating of Equal Weight and set a new price target of $105.00

    3/9/26 9:07:38 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Zions Bancorp upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Zions Bancorp from Neutral to Outperform and set a new price target of $65.00

    3/9/26 8:45:59 AM ET
    $ZION
    Major Banks
    Finance

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Financials

    Live finance-specific insights

    View All

    SL Green Announces the Sale of 7 Dey Street

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it has entered into a contract to sell the residential and retail components of 7 Dey Street for total consideration of $222.6 million to GO Residential (TSX:GO). SL Green will retain ownership of the 26,000 square foot office component of the property. The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions. "This transaction continues the execution of a deliberate strategy to illuminate the value of selected assets and unlock embedded value," said Harrison Sitomer, President and Chief Investment Offic

    3/16/26 6:19:33 PM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

    Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, 2025. Press Release Highlights Reported fourth quarter revenue of $451,000 Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities Announced list price for Proteus of $425,000 Announced 2026 Financial Guidance

    3/3/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SL Green Promotes Harrison Sitomer to President and Chief Investment Officer

    NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced the promotion of Harrison Sitomer to President and Chief Investment Officer. In addition, the Company extended the contracts of Chief Financial Officer, Matthew DiLiberto, and Chief Operating Officer, Edward Piccinich, through the end of 2028. Sitomer's promotion reflects the continuation of a leadership trajectory that has been years in the making. Sitomer began his career at SL Green as an intern and steadily rose through the organization, serving in a variety of investment roles before assuming the role of Chief Investment Officer in January of 2022. His d

    3/2/26 7:50:00 AM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Gorilla Technology Group Inc.

    SC 13G/A - Gorilla Technology Group Inc. (0001903145) (Subject)

    12/6/24 9:25:12 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by DURECT Corporation

    SC 13G/A - DURECT CORP (0001082038) (Subject)

    11/19/24 5:10:25 PM ET
    $DRRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ALPS
    $AWH
    $CBIO
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors

    IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and former Chairman and CEO of Allergan, Inc., to its Board of Directors. "David is one of the most accomplished leaders in eye care, with a strong track record of translating innovation into global impact," said Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman of Tarsus. "His experience building some of the most successful franchises in our industry will be invaluable as we scale XDEMVY, advance our pipeline and position Tarsus for sustained growth. We are honored

    2/18/26 8:30:00 AM ET
    $TARS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Richardson Electronics' Canvys Division Appoints Rainer Bornwasser as VP of Global Sales

    LAFOX, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL), today announced that Rainer Bornwasser has been appointed Vice President of Global Sales for Canvys – Visual Technology Solutions, a division of Richardson Electronics, effective February 1, 2026. The appointment underscores Richardson Electronics' commitment to accelerating global growth, expanding strategic OEM partnerships, and strengthening its position in high-value medical and industrial display markets through its Canvys division. For conference questions and registration information, please contact your Benchmark representative. Mr. Bornwasser brings more than 30 years of international sales

    2/3/26 11:00:00 AM ET
    $RELL
    Electronic Components
    Technology